An Open-Label, Multicenter, Randomized, Phase III Study Comparing Combination IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Advanced (IIIB/IV) Non-Small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase II
Latest Information Update: 22 Apr 2015
At a glance
- Drugs Docetaxel; Topotecan
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 14 Oct 2008 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 02 Sep 2005 New trial record.